Tumor-induced immunosuppression occurs by inducing the expression of immunosuppressive molecules or their receptors, including programmed death-ligand 1/programmed death-1 (PD-L1/PD-1), which inactivate T lymphocytes to achieve tumor immune escape (Jiang et al., 2019). This evidence concerns the gene CD274 and neoplasm.